Working... Menu
Trial record 9 of 57 for:    Recruiting, Not yet recruiting, Available Studies | Arthroscopy

Effect of Warmed Irrigation in Hip Arthroscopy Undergoing Hip Arthroscopy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03453866
Recruitment Status : Recruiting
First Posted : March 5, 2018
Last Update Posted : June 13, 2019
Information provided by (Responsible Party):
University of Colorado, Denver

Brief Summary:
The purpose of this study is to determine if pre-warming of arthroscopic fluid reduces immediate post-surgical pain in hip arthroscopy patients. The investigators hypothesize there will be a significant decrease in the Visual Analog Score (VAS) measured 30 minutes post-operatively in the warmed fluid group compared to the control group. Secondary outcome measures to be collected will include VAS scores 60 minutes after surgery and on post-operative day (POD) one. Additionally, the investigators will collect post-operative temperature measured 30 and 60 minutes post-operatively as well as morphine equivalent dosing in PACU and at the two-week follow up visit.

Condition or disease Intervention/treatment Phase
Femoro Acetabular Impingement Pain, Postoperative Procedure: Warmed Arthroscopic Fluids Procedure: Room Temperature Arthroscopic Fluids Not Applicable

Detailed Description:
In the last two decades, hip arthroscopy for the treatment of femoral acetabular impingement has increased rapidly. Currently, over 30k hip scopes are performed annually in the United States (incidence 1.06 per 10K). Due to anatomical differences, hip arthroscopy procedures have the potential for significant fluid extravasation when compared to knee arthroscopy. A 2011 study on hip arthroscopy showed on average 9.68 liters of fluid were used for a standard hip procedure; of that 1.13 liters absorbed into the surrounding soft tissues. A recent systematic review and meta-analysis showed warming of arthroscopic fluids significantly decreased the risk of hypothermia during hip arthroscopy. Additionally, active warming has been shown to decrease the rate of surgical site infection during numerous procedures. In total knee arthroplasty patients, a forced air warming gown significantly reduced narcotic pain consumption compared to standard care. However, the benefits of active warming for decreasing post-operative pain has not been studied in hip arthroscopy patients. Specifically, the investigators were interested in the roll the pre-warming arthroscopic fluid plays in post-operative pain after hip arthroscopy. The purpose of this study is to see if pre-warming of arthroscopic fluid reduces immediate post-surgical pain and narcotic consumption in hip arthroscopy patients.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 60 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: Prospective Randomized Controlled Trial
Masking: Double (Participant, Outcomes Assessor)
Masking Description: Sealed Opaque Envelope
Primary Purpose: Treatment
Official Title: Effect of Warmed Irrigation Fluid on Immediate Post-operative Pain Scores in Patients Undergoing Hip Arthroscopy
Actual Study Start Date : February 9, 2018
Estimated Primary Completion Date : February 9, 2020
Estimated Study Completion Date : February 9, 2020

Arm Intervention/treatment
Experimental: Warmed Arthroscopic Fluids
Arthroscopic Fluids will be warmed to 38 degrees Celsius during procedure with active warming device. Temperature will be measured in real time.
Procedure: Warmed Arthroscopic Fluids
Warmed Arthroscopic Fluids

Active Comparator: Room Temperature Arthroscopic Fluids
Arthroscopic fluids will be kept at room temperature and will not be warmed per current standard of care. Temperature will be measured in real time.
Procedure: Room Temperature Arthroscopic Fluids
Room Temperature Arthroscopic Fluids

Primary Outcome Measures :
  1. Changes in Visual Analog Score [ Time Frame: Pre-operatively, 30 and 60 minutes after completion of surgery, Post Op Days 1 and 14. ]
    A Visual Analog Score (VAS) will be measured pre-operatively, 30 and 60 minutes after patient arrival in the post-anesthesia care unit (PACU). Additionally, VAS will be collected in the clinic on post-operative day (POD) 1 and POD 14. The visual analog scale measures subject reported pain on a scale of 0-100 with a score of 0 indicating no pain and 100 indicating the worst pain possible.

Secondary Outcome Measures :
  1. Changes in Temperature [ Time Frame: 30-60 minutes after after completion of surgery ]
    Subject core temperature will be collected 30 and 60 minutes after arrival in PACU. The method for collection will be done via current standard of care.

  2. Morphine Equivalent Dosage (MED) [ Time Frame: After completion of surgery and at the 2-week Post Operative Visit ]
    Morphine equivalent dose (MED) will be calculated in PACU and at the subject's routine two-week post-operative appointment via medication reconciliation.

Other Outcome Measures:
  1. Hip Outcomes Score (HOS) [ Time Frame: Pre-operatively ]
    The HOS has been validated in patients with femoral acetabular impingement and has two subscales (Activities of Daily Living and Sports). The ADL subscale contained 19 items pertaining to basic daily activities, and the sports subscale contained 9 items pertaining to higher-level activities. The ADL and sports subscales are scored separately. The response to each item on the ADL subscale is scored from 4 to 0, with 4 indicating "no difficulty" and 0 indicating "unable to do." The scores for each of the items are added together to obtain a total. The total number of items with a response is multiplied by 4 to obtain the highest potential score. The item score total is divided by the highest potential score. This value is then multiplied by 100 to obtain a percentage. The sports subscale is scored in a similar manner, with the highest potential score being 36. A higher score represents a higher level of physical function.

  2. Veterans Rand 12 (VR-12) [ Time Frame: Pre-Operatively ]
    The Veterans RAND 12 Item Health Survey (VR-12) is a brief, generic, multi-use, self-administered health survey comprised of 12 items. The instrument is primarily used to measure health related quality of life and to estimate disease. The 12 items in the questionnaire correspond to eight principal physical and mental health domains including general health perceptions; physical functioning; role limitations due to physical and emotional problems; bodily pain; energy-fatigue, social functioning and mental health. The 12 items are summarized into two scores, a Physical Component Score (PCS) and a Mental Component Score (MCS). PCS and MCS summary scores are standardized using a t-score transformation and normed to a U.S. population of a score of 50 and a standard deviation of 10. The subscales are not combined or averaged for a total score. A Higher score represents a higher function.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years to 65 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • All patients aged 18-65 years with a confirmed diagnosis of Femoroacetabular impingement (FAI)
  • Required hip arthroscopy will be considered for the study
  • Pre-operative history and physical exam
  • Magnetic resonance imaging (MRI) before being indicated for arthroscopic surgery

Exclusion Criteria:

  • Taking narcotic medications at baseline
  • Have a history of complex regional pain syndrome,
  • Have hip arthritis,
  • Have undergone previous hip arthroscopic surgery, or
  • Are deemed incapable by the Principal Investigator of completing the study.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT03453866

Layout table for location contacts
Contact: James Genuario, MD 303-694-3333
Contact: Michael Rose, MD 303-694-3333

Layout table for location information
United States, Colorado
Steadman Hawkins Clinic, University of Colorado Denver Recruiting
Greenwood Village, Colorado, United States, 80111
Contact: James Genuario, MD    303-694-3333   
Contact: Michael Rose, MD    303-694-3333   
Sponsors and Collaborators
University of Colorado, Denver
Layout table for investigator information
Principal Investigator: James Genuario, MD University of Colorado, Denver

Layout table for additonal information
Responsible Party: University of Colorado, Denver Identifier: NCT03453866     History of Changes
Other Study ID Numbers: 17-2399
First Posted: March 5, 2018    Key Record Dates
Last Update Posted: June 13, 2019
Last Verified: June 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by University of Colorado, Denver:
Hip Arthroscopy
Warmed Fluids

Additional relevant MeSH terms:
Layout table for MeSH terms
Femoracetabular Impingement
Pain, Postoperative
Postoperative Complications
Pathologic Processes
Neurologic Manifestations
Signs and Symptoms
Joint Diseases
Musculoskeletal Diseases